翰宇药业：向深圳市高新投集团有限公司及其下属子公司申请融资 融资总额不超过7亿元

Core Viewpoint - The company has approved a financing proposal to raise up to RMB 700 million from Shenzhen High-tech Investment Group Co., Ltd. and its subsidiaries, with a term not exceeding 12 months [1] Financing Details - The total financing amount is capped at RMB 700 million, covering multiple products [1] - The financing will be secured by collateral from the company's Pingshan branch and Dali subsidiary [1] - The specific terms will be finalized in the actual signed contract [1]